WASHINGTON, Nov. 7, 2013 /PRNewswire via COMTEX/ -- Vanda Pharmaceuticals Inc. (Vanda) /quotes/zigman/99189/delayed/quotes/nls/vnda VNDA -0.02% , a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
